Given the uncertainty over the treatment effects of mTOR inhibitor and the difficulties in the interpretation of the clinical studies, we therefore carried out a systematic review to assess the efficacy and safety of mTOR inhibitor in the treatment of children with TSC. The gene discussed is MTOR; the disease is tuberous sclerosis.